A study on the efficacy and safety of aprepitant injection in preventing and treating nausea and vomiting induced by platinum‐based chemotherapy in lung cancer

This study aimed to assess the clinical efficacy and safety of aprepitant injection in preventing and treating nausea and vomiting induced by platinum‐based chemotherapy in lung cancer patients. Forty‐eight patients with advanced first‐line lung cancer undergoing cisplatin‐ or carboplatin‐based chem...

Full description

Saved in:
Bibliographic Details
Published in:Precision medical sciences 2024-03, Vol.13 (1), p.63-68
Main Authors: Fei, Yan, siwen, Liu, xiaoyou, Li, Xiaoyue, Xu, Yuan, Wu, Bo, Shen
Format: Article
Language:English
Subjects:
Alcohol
Antiemetics
aprepitant injection
Cancer therapies
Cardiac function
Chemotherapy
Drug dosages
Lung cancer
Males
Motion sickness
Nausea
Pharmaceuticals
prophylactic antiemetic
Quality of life
Vomiting
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aimed to assess the clinical efficacy and safety of aprepitant injection in preventing and treating nausea and vomiting induced by platinum‐based chemotherapy in lung cancer patients. Forty‐eight patients with advanced first‐line lung cancer undergoing cisplatin‐ or carboplatin‐based chemotherapy were randomly assigned to either the experimental group or the control group, with 24 patients in each group. The control group received dexamethasone and palonosetron for vomiting prevention, whereas the experimental group received dexamethasone, palonosetron, and aprepitant injection. The study compared the incidence of acute and delayed vomiting, functional life index (FLIE) scores for nausea and vomiting at 24 and 120 h postchemotherapy and the occurrence of adverse drug reactions between the two groups. The effective control rate of acute‐phase vomiting in the treatment group was 83.33%, significantly higher than 45.83% in the control group, with a statistically significant difference (p 
ISSN:2642-2514
2642-2514
DOI:10.1002/prm2.12124